C
Microbix Biosystems Inc.
MBXBF
$0.2992
$0.00511.73%
C
Hold
1/22/2025Upgraded
Microbix Biosystems Inc. (MBXBF) was upgraded to C from C- on 1/22/2025 due to a noticeable increase in the growth index, total return index and volatility index. EBIT increased 331.37% from $120.8 to $521.1, earnings per share increased from $0.0013 to $0.0024, and total revenue increased 24.8% from $3.7M to $4.61M.
Microbix Biosystems Inc. (MBXBF) was upgraded to C from C- on 1/22/2025 due to a noticeable increase in the growth index, total return index and volatility index. EBIT increased 331.37% from $120.8 to $521.1, earnings per share increased from $0.0013 to $0.0024, and total revenue increased 24.8% from $3.7M to $4.61M.
C
Hold
9/12/2024Upgraded
Microbix Biosystems Inc. (MBXBF) was upgraded to C- from D+ on 9/12/2024 due to an increase in the growth index, valuation index and total return index. Operating cash flow increased 64.77% from $622.5 to $1.03M.
Microbix Biosystems Inc. (MBXBF) was upgraded to C- from D+ on 9/12/2024 due to an increase in the growth index, valuation index and total return index. Operating cash flow increased 64.77% from $622.5 to $1.03M.
D
Sell
7/29/2024Downgrade
Microbix Biosystems Inc. (MBXBF) was downgraded to D+ from C- on 7/29/2024 due to a decline in the valuation index, total return index and volatility index.
Microbix Biosystems Inc. (MBXBF) was downgraded to D+ from C- on 7/29/2024 due to a decline in the valuation index, total return index and volatility index.
C
Hold
7/12/2024Upgraded
Microbix Biosystems Inc. (MBXBF) was upgraded to C- from D+ on 7/12/2024 due to an increase in the valuation index and volatility index.
Microbix Biosystems Inc. (MBXBF) was upgraded to C- from D+ on 7/12/2024 due to an increase in the valuation index and volatility index.
D
Sell
6/20/2024Downgrade
Microbix Biosystems Inc. (MBXBF) was downgraded to D+ from C- on 6/20/2024 due to a decline in the valuation index, total return index and volatility index.
Microbix Biosystems Inc. (MBXBF) was downgraded to D+ from C- on 6/20/2024 due to a decline in the valuation index, total return index and volatility index.
C
Hold
6/5/2024Upgraded
Microbix Biosystems Inc. (MBXBF) was upgraded to C- from D+ on 6/5/2024 due to an increase in the valuation index, volatility index and total return index.
Microbix Biosystems Inc. (MBXBF) was upgraded to C- from D+ on 6/5/2024 due to an increase in the valuation index, volatility index and total return index.
D
Sell
5/23/2024Downgrade
Microbix Biosystems Inc. (MBXBF) was downgraded to D+ from C- on 5/23/2024 due to a decline in the total return index, volatility index and efficiency index.
Microbix Biosystems Inc. (MBXBF) was downgraded to D+ from C- on 5/23/2024 due to a decline in the total return index, volatility index and efficiency index.
C
Hold
4/11/2024Downgrade
Microbix Biosystems Inc. (MBXBF) was downgraded to C- from C on 4/11/2024 due to a decline in the volatility index and total return index.
Microbix Biosystems Inc. (MBXBF) was downgraded to C- from C on 4/11/2024 due to a decline in the volatility index and total return index.
C
Hold
3/8/2024Upgraded
Microbix Biosystems Inc. (MBXBF) was upgraded to C from C- on 3/8/2024 due to an increase in the total return index.
Microbix Biosystems Inc. (MBXBF) was upgraded to C from C- on 3/8/2024 due to an increase in the total return index.
C
Hold
2/16/2024Upgraded
Microbix Biosystems Inc. (MBXBF) was upgraded to C- from D on 2/16/2024 due to a significant increase in the growth index, valuation index and efficiency index. EBIT increased 355.78% from -$738.5 to $1.89M, operating cash flow increased 190.65% from -$1.09M to $984.2, and total revenue increased 94.39% from $3.18M to $6.18M.
Microbix Biosystems Inc. (MBXBF) was upgraded to C- from D on 2/16/2024 due to a significant increase in the growth index, valuation index and efficiency index. EBIT increased 355.78% from -$738.5 to $1.89M, operating cash flow increased 190.65% from -$1.09M to $984.2, and total revenue increased 94.39% from $3.18M to $6.18M.
D
Sell
2/10/2023Downgrade
Microbix Biosystems Inc. (MBXBF) was downgraded to D from D+ on 2/10/2023 due to a major decline in the valuation index, efficiency index and growth index. Operating cash flow declined 568.72% from $112.2 to -$525.9, EBIT declined 349.82% from -$196.9 to -$885.7, and net income declined 169.1% from -$355.7 to -$957.2.
Microbix Biosystems Inc. (MBXBF) was downgraded to D from D+ on 2/10/2023 due to a major decline in the valuation index, efficiency index and growth index. Operating cash flow declined 568.72% from $112.2 to -$525.9, EBIT declined 349.82% from -$196.9 to -$885.7, and net income declined 169.1% from -$355.7 to -$957.2.
D
Sell
12/27/2022Downgrade
Microbix Biosystems Inc. (MBXBF) was downgraded to D+ from C on 12/27/2022 due to a large decline in the valuation index, growth index and efficiency index. Earnings per share declined from $0.0031 to -$0.0029, net income declined 171.11% from $500.2 to -$355.7, and EBIT declined 131.07% from $633.7 to -$196.9.
Microbix Biosystems Inc. (MBXBF) was downgraded to D+ from C on 12/27/2022 due to a large decline in the valuation index, growth index and efficiency index. Earnings per share declined from $0.0031 to -$0.0029, net income declined 171.11% from $500.2 to -$355.7, and EBIT declined 131.07% from $633.7 to -$196.9.
C
Hold
9/30/2022Upgraded
Microbix Biosystems Inc. (MBXBF) was upgraded to C from C- on 9/30/2022 due to an increase in the valuation index and volatility index.
Microbix Biosystems Inc. (MBXBF) was upgraded to C from C- on 9/30/2022 due to an increase in the valuation index and volatility index.
C
Hold
8/15/2022Downgrade
Microbix Biosystems Inc. (MBXBF) was downgraded to C- from C on 8/15/2022 due to a significant decline in the total return index, growth index and volatility index. Earnings per share declined from $0.0039 to $0.0031, and EBIT declined 14.27% from $739.5 to $634.
Microbix Biosystems Inc. (MBXBF) was downgraded to C- from C on 8/15/2022 due to a significant decline in the total return index, growth index and volatility index. Earnings per share declined from $0.0039 to $0.0031, and EBIT declined 14.27% from $739.5 to $634.
C
Hold
12/27/2021Upgraded
Microbix Biosystems Inc. (MBXBF) was upgraded to C from D+ on 12/27/2021 due to a significant increase in the efficiency index, valuation index and growth index. Operating cash flow increased 331.31% from -$556.4 to $1.29M, total capital increased 11.77% from $18.6M to $20.79M, and total revenue increased 0.66% from $4.44M to $4.47M.
Microbix Biosystems Inc. (MBXBF) was upgraded to C from D+ on 12/27/2021 due to a significant increase in the efficiency index, valuation index and growth index. Operating cash flow increased 331.31% from -$556.4 to $1.29M, total capital increased 11.77% from $18.6M to $20.79M, and total revenue increased 0.66% from $4.44M to $4.47M.
D
Sell
11/9/2021Upgraded
Microbix Biosystems Inc. (MBXBF) was upgraded to D+ from D- on 11/09/2021.
Microbix Biosystems Inc. (MBXBF) was upgraded to D+ from D- on 11/09/2021.
D
Sell
11/8/2021Downgrade
Microbix Biosystems Inc. (MBXBF) was downgraded to D- from D+ on 11/8/2021 due to a decline in the valuation index.
Microbix Biosystems Inc. (MBXBF) was downgraded to D- from D+ on 11/8/2021 due to a decline in the valuation index.
D
Sell
8/30/2021Upgraded
Microbix Biosystems Inc. (MBXBF) was upgraded to D+ from D on 8/30/2021 due to a substantial increase in the solvency index, total return index and volatility index. The quick ratio increased from 0.77 to 2.8, and debt to equity declined from 0.73 to 0.37.
Microbix Biosystems Inc. (MBXBF) was upgraded to D+ from D on 8/30/2021 due to a substantial increase in the solvency index, total return index and volatility index. The quick ratio increased from 0.77 to 2.8, and debt to equity declined from 0.73 to 0.37.
D
Sell
12/3/2020Downgrade
Microbix Biosystems Inc. (MBXBF) was downgraded to D from D+ on 12/3/2020 due to a decline in the valuation index and volatility index.
Microbix Biosystems Inc. (MBXBF) was downgraded to D from D+ on 12/3/2020 due to a decline in the valuation index and volatility index.
D
Sell
10/27/2020Upgraded
Microbix Biosystems Inc. (MBXBF) was upgraded to D+ from D on 10/27/2020 due to an increase in the volatility index and total return index.
Microbix Biosystems Inc. (MBXBF) was upgraded to D+ from D on 10/27/2020 due to an increase in the volatility index and total return index.
D
Sell
10/12/2020Downgrade
Microbix Biosystems Inc. (MBXBF) was downgraded to D from D+ on 10/12/2020 due to a decline in the volatility index and total return index.
Microbix Biosystems Inc. (MBXBF) was downgraded to D from D+ on 10/12/2020 due to a decline in the volatility index and total return index.
D
Sell
6/5/2020Upgraded
Microbix Biosystems Inc. (MBXBF) was upgraded to D+ from D on 6/5/2020 due to a noticeable increase in the volatility index, growth index and total return index. EBIT increased 115.71% from -$233.6 to $36.7, earnings per share increased from -$0.0046 to -$0.0016, and total revenue increased 37.98% from $1.55M to $2.14M.
Microbix Biosystems Inc. (MBXBF) was upgraded to D+ from D on 6/5/2020 due to a noticeable increase in the volatility index, growth index and total return index. EBIT increased 115.71% from -$233.6 to $36.7, earnings per share increased from -$0.0046 to -$0.0016, and total revenue increased 37.98% from $1.55M to $2.14M.
D
Sell
2/18/2020Downgrade
Microbix Biosystems Inc. (MBXBF) was downgraded to D from D+ on 2/18/2020 due to a major decline in the growth index, total return index and volatility index. Earnings per share declined from -$0.001 to -$0.0046, EBIT declined 325.27% from $103.7 to -$233.6, and operating cash flow declined 58.59% from $435.2 to $180.2.
Microbix Biosystems Inc. (MBXBF) was downgraded to D from D+ on 2/18/2020 due to a major decline in the growth index, total return index and volatility index. Earnings per share declined from -$0.001 to -$0.0046, EBIT declined 325.27% from $103.7 to -$233.6, and operating cash flow declined 58.59% from $435.2 to $180.2.
D
Sell
2/4/2020Upgraded
Microbix Biosystems Inc. (MBXBF) was upgraded to D+ from D on 2/4/2020 due to a large increase in the growth index, efficiency index and solvency index. Operating cash flow increased 388.59% from -$150.8 to $435.2, EBIT increased 75.47% from $59.1 to $103.7, and net income increased 74.13% from -$143 to -$37.
Microbix Biosystems Inc. (MBXBF) was upgraded to D+ from D on 2/4/2020 due to a large increase in the growth index, efficiency index and solvency index. Operating cash flow increased 388.59% from -$150.8 to $435.2, EBIT increased 75.47% from $59.1 to $103.7, and net income increased 74.13% from -$143 to -$37.
D
Sell
8/13/2019Downgrade
Microbix Biosystems Inc. (MBXBF) was downgraded to D from D+ on 8/13/2019 due to a large decline in the growth index, total return index and solvency index. Earnings per share declined from $0.003 to -$0.0015, EBIT declined 89.59% from $567.5 to $59.1, and total revenue declined 27.33% from $3.2M to $2.33M.
Microbix Biosystems Inc. (MBXBF) was downgraded to D from D+ on 8/13/2019 due to a large decline in the growth index, total return index and solvency index. Earnings per share declined from $0.003 to -$0.0015, EBIT declined 89.59% from $567.5 to $59.1, and total revenue declined 27.33% from $3.2M to $2.33M.
D
Sell
7/9/2019Upgraded
Microbix Biosystems Inc. (MBXBF) was upgraded to D+ from D on 7/9/2019 due to a large increase in the total return index, volatility index and valuation index.
Microbix Biosystems Inc. (MBXBF) was upgraded to D+ from D on 7/9/2019 due to a large increase in the total return index, volatility index and valuation index.
D
Sell
6/24/2019Downgrade
Microbix Biosystems Inc. (MBXBF) was downgraded to D from D+ on 6/24/2019 due to a decline in the total return index.
Microbix Biosystems Inc. (MBXBF) was downgraded to D from D+ on 6/24/2019 due to a decline in the total return index.
D
Sell
6/7/2019Upgraded
Microbix Biosystems Inc. (MBXBF) was upgraded to D+ from D on 6/7/2019 due to a major increase in the growth index, total return index and volatility index. EBIT increased 437.41% from $105.6 to $567.5, earnings per share increased from -$0.0009 to $0.003, and total revenue increased 71.6% from $1.86M to $3.2M.
Microbix Biosystems Inc. (MBXBF) was upgraded to D+ from D on 6/7/2019 due to a major increase in the growth index, total return index and volatility index. EBIT increased 437.41% from $105.6 to $567.5, earnings per share increased from -$0.0009 to $0.003, and total revenue increased 71.6% from $1.86M to $3.2M.
D
Sell
1/29/2019Upgraded
Microbix Biosystems Inc. (MBXBF) was upgraded to D from D- on 1/29/2019 due to an increase in the total return index and volatility index.
Microbix Biosystems Inc. (MBXBF) was upgraded to D from D- on 1/29/2019 due to an increase in the total return index and volatility index.
D
Sell
1/7/2019Downgrade
Microbix Biosystems Inc. (MBXBF) was downgraded to D- from D on 1/7/2019 due to a substantial decline in the total return index, efficiency index and growth index. Net income declined 894,728.57% from $700 to -$6.26M, EBIT declined 139.63% from $167.8 to -$66.5, and total capital declined 32.17% from $18.95M to $12.85M.
Microbix Biosystems Inc. (MBXBF) was downgraded to D- from D on 1/7/2019 due to a substantial decline in the total return index, efficiency index and growth index. Net income declined 894,728.57% from $700 to -$6.26M, EBIT declined 139.63% from $167.8 to -$66.5, and total capital declined 32.17% from $18.95M to $12.85M.
D
Sell
11/16/2017Downgrade
Microbix Biosystems Inc. (MBXBF) was downgraded to D from D+ on 11/16/2017 due to a decline in the volatility index.
Microbix Biosystems Inc. (MBXBF) was downgraded to D from D+ on 11/16/2017 due to a decline in the volatility index.
D
Sell
9/1/2017Upgraded
Microbix Biosystems Inc. (MBXBF) was upgraded to D+ from D on 9/1/2017 due to an increase in the volatility index and total return index.
Microbix Biosystems Inc. (MBXBF) was upgraded to D+ from D on 9/1/2017 due to an increase in the volatility index and total return index.
D
Sell
8/16/2017Downgrade
Microbix Biosystems Inc. (MBXBF) was downgraded to D from D+ on 8/16/2017 due to a noticeable decline in the growth index, solvency index and valuation index. EBIT declined 80.52% from $250.5 to $48.8, earnings per share declined from $0.0023 to $0.0015, and the quick ratio declined from 0.27 to 0.19.
Microbix Biosystems Inc. (MBXBF) was downgraded to D from D+ on 8/16/2017 due to a noticeable decline in the growth index, solvency index and valuation index. EBIT declined 80.52% from $250.5 to $48.8, earnings per share declined from $0.0023 to $0.0015, and the quick ratio declined from 0.27 to 0.19.
D
Sell
8/15/2017Upgraded
Microbix Biosystems Inc. (MBXBF) was upgraded to D+ from D on 8/15/2017 due to an increase in the volatility index and total return index.
Microbix Biosystems Inc. (MBXBF) was upgraded to D+ from D on 8/15/2017 due to an increase in the volatility index and total return index.
D
Sell
7/31/2017Downgrade
Microbix Biosystems Inc. (MBXBF) was downgraded to D from D+ on 7/31/2017 due to a decline in the volatility index and total return index.
Microbix Biosystems Inc. (MBXBF) was downgraded to D from D+ on 7/31/2017 due to a decline in the volatility index and total return index.
D
Sell
7/14/2017Upgraded
Microbix Biosystems Inc. (MBXBF) was upgraded to D+ from D on 7/14/2017 due to a major increase in the growth index, total return index and volatility index. EBIT increased 209.01% from -$229.8 to $250.5, earnings per share increased from -$0.0285 to $0.0023, and total revenue increased 36.61% from $1.46M to $2M.
Microbix Biosystems Inc. (MBXBF) was upgraded to D+ from D on 7/14/2017 due to a major increase in the growth index, total return index and volatility index. EBIT increased 209.01% from -$229.8 to $250.5, earnings per share increased from -$0.0285 to $0.0023, and total revenue increased 36.61% from $1.46M to $2M.
D
Sell
2/15/2017Downgrade
Microbix Biosystems Inc. (MBXBF) was downgraded to D from D+ on 2/15/2017 due to a substantial decline in the efficiency index, total return index and growth index. Earnings per share declined from $0.0075 to -$0.0285, net income declined 464.55% from $661.3 to -$2.41M, and EBIT declined 143.61% from $526.7 to -$229.7.
Microbix Biosystems Inc. (MBXBF) was downgraded to D from D+ on 2/15/2017 due to a substantial decline in the efficiency index, total return index and growth index. Earnings per share declined from $0.0075 to -$0.0285, net income declined 464.55% from $661.3 to -$2.41M, and EBIT declined 143.61% from $526.7 to -$229.7.
D
Sell
8/16/2016Downgrade
Microbix Biosystems Inc. (MBXBF) was downgraded to D+ from C- on 8/16/2016 due to a substantial decline in the growth index, solvency index and volatility index. EBIT declined 87.24% from $260.9 to $33.3, earnings per share declined from $0.0015 to $0.0008, and total revenue declined 12.17% from $1.99M to $1.75M.
Microbix Biosystems Inc. (MBXBF) was downgraded to D+ from C- on 8/16/2016 due to a substantial decline in the growth index, solvency index and volatility index. EBIT declined 87.24% from $260.9 to $33.3, earnings per share declined from $0.0015 to $0.0008, and total revenue declined 12.17% from $1.99M to $1.75M.
C
Hold
8/12/2016Upgraded
Microbix Biosystems Inc. (MBXBF) was upgraded to C- from D+ on 8/12/2016 due to an increase in the total return index and volatility index.
Microbix Biosystems Inc. (MBXBF) was upgraded to C- from D+ on 8/12/2016 due to an increase in the total return index and volatility index.
D
Sell
7/5/2016Downgrade
Microbix Biosystems Inc. (MBXBF) was downgraded to D+ from C- on 7/5/2016 due to a decline in the volatility index and total return index.
Microbix Biosystems Inc. (MBXBF) was downgraded to D+ from C- on 7/5/2016 due to a decline in the volatility index and total return index.
C
Hold
6/17/2016Upgraded
Microbix Biosystems Inc. (MBXBF) was upgraded to C- from D+ on 6/17/2016 due to an increase in the total return index.
Microbix Biosystems Inc. (MBXBF) was upgraded to C- from D+ on 6/17/2016 due to an increase in the total return index.
D
Sell
6/2/2016Downgrade
Microbix Biosystems Inc. (MBXBF) was downgraded to D+ from C- on 6/2/2016 due to a decline in the growth index and volatility index.
Microbix Biosystems Inc. (MBXBF) was downgraded to D+ from C- on 6/2/2016 due to a decline in the growth index and volatility index.
C
Hold
5/18/2016Upgraded
Microbix Biosystems Inc. (MBXBF) was upgraded to C- from D+ on 5/18/2016 due to a significant increase in the growth index, total return index and valuation index. EBIT increased 239.97% from -$186.4 to $260.9, earnings per share increased from -$0.003 to $0.0015, and total revenue increased 149.97% from $796.7 to $1.99M.
Microbix Biosystems Inc. (MBXBF) was upgraded to C- from D+ on 5/18/2016 due to a significant increase in the growth index, total return index and valuation index. EBIT increased 239.97% from -$186.4 to $260.9, earnings per share increased from -$0.003 to $0.0015, and total revenue increased 149.97% from $796.7 to $1.99M.
D
Sell
3/28/2016Upgraded
Microbix Biosystems Inc. (MBXBF) was upgraded to D+ from D on 3/28/2016 due to an increase in the total return index and volatility index.
Microbix Biosystems Inc. (MBXBF) was upgraded to D+ from D on 3/28/2016 due to an increase in the total return index and volatility index.
D
Sell
3/11/2016Downgrade
Microbix Biosystems Inc. (MBXBF) was downgraded to D from C- on 3/11/2016 due to a major decline in the volatility index, total return index and valuation index.
Microbix Biosystems Inc. (MBXBF) was downgraded to D from C- on 3/11/2016 due to a major decline in the volatility index, total return index and valuation index.
C
Hold
2/17/2016Downgrade
Microbix Biosystems Inc. (MBXBF) was downgraded to C- from C on 2/17/2016 due to a significant decline in the growth index, valuation index and total return index. Earnings per share declined from $0.0035 to -$0.003, EBIT declined 180.59% from $231.3 to -$186.4, and operating cash flow declined 136.74% from $64.5 to -$23.7.
Microbix Biosystems Inc. (MBXBF) was downgraded to C- from C on 2/17/2016 due to a significant decline in the growth index, valuation index and total return index. Earnings per share declined from $0.0035 to -$0.003, EBIT declined 180.59% from $231.3 to -$186.4, and operating cash flow declined 136.74% from $64.5 to -$23.7.
C
Hold
1/19/2016Downgrade
Microbix Biosystems Inc. (MBXBF) was downgraded to C from C+ on 1/19/2016 due to a decline in the total return index.
Microbix Biosystems Inc. (MBXBF) was downgraded to C from C+ on 1/19/2016 due to a decline in the total return index.
C
Hold
1/4/2016Upgraded
Microbix Biosystems Inc. (MBXBF) was upgraded to C+ from C- on 1/4/2016 due to a significant increase in the growth index, valuation index and efficiency index. Net income increased 361.23% from $66.8 to $308.1, and earnings per share increased from $0.0008 to $0.0035.
Microbix Biosystems Inc. (MBXBF) was upgraded to C+ from C- on 1/4/2016 due to a significant increase in the growth index, valuation index and efficiency index. Net income increased 361.23% from $66.8 to $308.1, and earnings per share increased from $0.0008 to $0.0035.
C
Hold
12/31/2015Upgraded
Microbix Biosystems Inc. (MBXBF) was upgraded to C- from D+ on 12/31/2015 due to an increase in the growth index, total return index and efficiency index. EBIT increased 50% from $172.6 to $258.9, and total capital increased 3.15% from $15.34M to $15.82M.
Microbix Biosystems Inc. (MBXBF) was upgraded to C- from D+ on 12/31/2015 due to an increase in the growth index, total return index and efficiency index. EBIT increased 50% from $172.6 to $258.9, and total capital increased 3.15% from $15.34M to $15.82M.
D
Sell
6/29/2015Downgrade
Microbix Biosystems Inc. (MBXBF) was downgraded to D+ from C- on 6/29/2015 due to a significant decline in the volatility index, solvency index and growth index. EBIT declined 23.53% from $225.7 to $172.6, and the quick ratio declined from 1.2 to 1.08.
Microbix Biosystems Inc. (MBXBF) was downgraded to D+ from C- on 6/29/2015 due to a significant decline in the volatility index, solvency index and growth index. EBIT declined 23.53% from $225.7 to $172.6, and the quick ratio declined from 1.2 to 1.08.
C
Hold
3/2/2015Upgraded
Microbix Biosystems Inc. (MBXBF) was upgraded to C- from D+ on 3/2/2015 due to an increase in the solvency index and valuation index.
Microbix Biosystems Inc. (MBXBF) was upgraded to C- from D+ on 3/2/2015 due to an increase in the solvency index and valuation index.
D
Sell
2/13/2015Downgrade
Microbix Biosystems Inc. (MBXBF) was downgraded to D+ from C- on 2/13/2015 due to a substantial decline in the growth index, total return index and efficiency index. EBIT declined 796.6% from -$32.4 to $225.7, operating cash flow declined 119.11% from -$899.7 to $171.9, and net income declined 100.53% from -$323 to $1.7.
Microbix Biosystems Inc. (MBXBF) was downgraded to D+ from C- on 2/13/2015 due to a substantial decline in the growth index, total return index and efficiency index. EBIT declined 796.6% from -$32.4 to $225.7, operating cash flow declined 119.11% from -$899.7 to $171.9, and net income declined 100.53% from -$323 to $1.7.
C
Hold
1/27/2015Downgrade
Microbix Biosystems Inc. (MBXBF) was downgraded to C- from C on 1/27/2015 due to a significant decline in the valuation index, growth index and efficiency index. Operating cash flow declined 560.68% from $195.3 to -$899.7, net income declined 267.27% from $193.1 to -$323, and earnings per share declined from $0.0028 to -$0.0044.
Microbix Biosystems Inc. (MBXBF) was downgraded to C- from C on 1/27/2015 due to a significant decline in the valuation index, growth index and efficiency index. Operating cash flow declined 560.68% from $195.3 to -$899.7, net income declined 267.27% from $193.1 to -$323, and earnings per share declined from $0.0028 to -$0.0044.
C
Hold
7/1/2014Upgraded
Microbix Biosystems Inc. (MBXBF) was upgraded to C from C- on 7/1/2014 due to a large increase in the growth index, solvency index and valuation index. Operating cash flow increased 225.11% from -$87.2 to -$283.5, the quick ratio increased from 1.17 to 2.13, and earnings per share increased from $0.0017 to $0.0025.
Microbix Biosystems Inc. (MBXBF) was upgraded to C from C- on 7/1/2014 due to a large increase in the growth index, solvency index and valuation index. Operating cash flow increased 225.11% from -$87.2 to -$283.5, the quick ratio increased from 1.17 to 2.13, and earnings per share increased from $0.0017 to $0.0025.
C
Hold
4/1/2014Upgraded
Microbix Biosystems Inc. (MBXBF) was upgraded to C- from D+ on 4/1/2014 due to a significant increase in the volatility index, total return index and valuation index.
Microbix Biosystems Inc. (MBXBF) was upgraded to C- from D+ on 4/1/2014 due to a significant increase in the volatility index, total return index and valuation index.
OTC PK
04/02/2025 3:55PM Eastern
Quotes delayed
